Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Boni

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Surgical Oncology|March 3, 2004
Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contributionGiuliano Mariani, Paola Erba, Gianpiero Manca, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panelSergio Baldari, Giuseppe Boni, Roberto Bortolus, et al.
Nuclear Medicine Communications|August 21, 2004
Minimally invasive radioguided parathyroidectomy: an attractive therapeutic option for elderly patients with primary hyperparathyroidismDomenico Rubello, Dario Casara, Sandro Giannini, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose" protocolDomenico Rubello, Lorraine M Fig, Dario Casara, et al.
Nuclear Medicine Communications|February 1, 2007
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawalAngela Vaiano, A Claudio Traino, Giuseppe Boni, et al.
Nuclear Medicine Communications|October 26, 2013
Safety and antitumor efficacy of (153)Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancerElisa Borsò, Giuseppe Boni, Ilaria Pastina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2004
Radionuclide gastroesophageal motor studiesGiuliano Mariani, Giuseppe Boni, Marco Barreca, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2009
Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithiumDaniele Barbaro, Mariano Grosso, Giuseppe Boni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Preoperative localization and radioguided parathyroid surgeryGiuliano Mariani, Seza A Gulec, Domenico Rubello, et al.
Tumori|July 5, 2003
The role of somatostatin in vasogenic meningioma associated brain edemaSabina Pistolesi, Gabriella Fontanini, Laura Boldrini, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Surgical Oncology|March 3, 2004
Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contributionGiuliano Mariani, Paola Erba, Gianpiero Manca, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panelSergio Baldari, Giuseppe Boni, Roberto Bortolus, et al.
Nuclear Medicine Communications|August 21, 2004
Minimally invasive radioguided parathyroidectomy: an attractive therapeutic option for elderly patients with primary hyperparathyroidismDomenico Rubello, Dario Casara, Sandro Giannini, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose" protocolDomenico Rubello, Lorraine M Fig, Dario Casara, et al.
Nuclear Medicine Communications|February 1, 2007
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawalAngela Vaiano, A Claudio Traino, Giuseppe Boni, et al.
Nuclear Medicine Communications|October 26, 2013
Safety and antitumor efficacy of (153)Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancerElisa Borsò, Giuseppe Boni, Ilaria Pastina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2004
Radionuclide gastroesophageal motor studiesGiuliano Mariani, Giuseppe Boni, Marco Barreca, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2009
Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithiumDaniele Barbaro, Mariano Grosso, Giuseppe Boni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Preoperative localization and radioguided parathyroid surgeryGiuliano Mariani, Seza A Gulec, Domenico Rubello, et al.
Tumori|July 5, 2003
The role of somatostatin in vasogenic meningioma associated brain edemaSabina Pistolesi, Gabriella Fontanini, Laura Boldrini, et al.
Pageof 6